13.77 USD
▼-0.46-3.23%
盘后 13.40 0.00%
2026-11-20
市值
$148.01M
市盈率
—
EPS
-66.82
股息率
—
52 周区间
12.39 – 46.95
成交量
91.23K
Beta
2.13
目标价
53.00
52W 低 12.3952W 高 46.95
价格走势
公司简介
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company’s candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves’ disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.